| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |